Search

Your search keyword '"Kudo, Atsushi"' showing total 594 results

Search Constraints

Start Over You searched for: Author "Kudo, Atsushi" Remove constraint Author: "Kudo, Atsushi"
594 results on '"Kudo, Atsushi"'

Search Results

1. DeepMedcast: A Deep Learning Method for Generating Intermediate Weather Forecasts among Multiple NWP Models

3. Statistical Post-Processing for Gridded Temperature Prediction Using Encoder-Decoder-Based Deep Convolutional Neural Networks

7. PHOX2B is a Sensitive and Specific Marker for the Histopathological Diagnosis of Pheochromocytoma and Paraganglioma

10. Nationwide registry for patients with neuroendocrine neoplasm of pancreas, gastrointestinal tract, lungs, bronchi, or thymus in Japan

13. JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis

15. An Organoid Biobank of Neuroendocrine Neoplasms Enables Genotype-Phenotype Mapping

22. Gene expression profiling of pancreatic neuroendocrine carcinoma and mixed neuroendocrine-non-neuroendocrine neoplasm

27. Fatty Acid Binding Protein 4 (FABP4) Overexpression in Intratumoral Hepatic Stellate Cells within Hepatocellular Carcinoma with Metabolic Risk Factors

31. Inflation with Low Reheat Temperature and Cosmological Constraint on Stable Charged Massive Particles

36. Surgical Outcomes of Hepatocellular Carcinoma With Bile Duct Tumor Thrombus: A Korea–Japan Multicenter Study

38. Multi-center clinical evaluation of streptozocin-based chemotherapy for advanced pancreatic neuroendocrine tumors in Japan: focus on weekly regimens and monotherapy

41. Supplementary Table 3 from Acquired Resistance with Epigenetic Alterations Under Long-Term Antiangiogenic Therapy for Hepatocellular Carcinoma

42. Data from Acquired Resistance with Epigenetic Alterations Under Long-Term Antiangiogenic Therapy for Hepatocellular Carcinoma

43. Supplementary Table 1 from Acquired Resistance with Epigenetic Alterations Under Long-Term Antiangiogenic Therapy for Hepatocellular Carcinoma

44. Supplementary Table 2 from Acquired Resistance with Epigenetic Alterations Under Long-Term Antiangiogenic Therapy for Hepatocellular Carcinoma

45. RRM1 is mediated by histone acetylation through gemcitabine resistance and contributes to invasiveness and ECM remodeling in pancreatic cancer

Catalog

Books, media, physical & digital resources